Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?
aDepartment of Gastrointestinal Oncology, Institut Jules Bordet
bUniversité Libre de Bruxelles (ULB), Brussels, Belgium
Correspondence to Francesco Sclafani, MD, PhD, Department of Gastrointestinal Oncology, Institut Jules Bordet, Rue Meylemeersch 90, 1070 Anderlecht, Belgium. Tel: +32 2 541 7397; fax: +32 2 538 0858; e-mail: [email protected]
留言 (0)